APA

Junyent M., Parnell L. D., Lai C., Arnett D. K., Tsai M. Y., Kabagambe E. K., Straka R. J., Province M., An P., Smith C. E., Lee Y., Borecki I. & Ordovás J. M. (20110519). ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study. : Nutrition, metabolism, and cardiovascular diseases : NMCD.

Chicago

Junyent M, Parnell L D, Lai C-Q, Arnett D K, Tsai M Y, Kabagambe E K, Straka R J, Province M, An P, Smith C E, Lee Y-C, Borecki I and Ordovás J M. 20110519. ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study. : Nutrition, metabolism, and cardiovascular diseases : NMCD.

Harvard

Junyent M., Parnell L. D., Lai C., Arnett D. K., Tsai M. Y., Kabagambe E. K., Straka R. J., Province M., An P., Smith C. E., Lee Y., Borecki I. and Ordovás J. M. (20110519). ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study. : Nutrition, metabolism, and cardiovascular diseases : NMCD.

MLA

Junyent M, Parnell L D, Lai C-Q, Arnett D K, Tsai M Y, Kabagambe E K, Straka R J, Province M, An P, Smith C E, Lee Y-C, Borecki I and Ordovás J M. ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study. : Nutrition, metabolism, and cardiovascular diseases : NMCD. 20110519.